Page 13 - Pharmaceutical Development News Today

The Transmucosal Drug Delivery Devices Market is expected to grow at a CAGR of 8.62% and is poised to reach US$XX Billion by 2027 as compared to US$XX

/PRNewswire/ -- Corporate Updates YTD SWK has closed two financings totaling up to $14.0 million Enteris BioPharma subsidiary announced completion of...

Prof. Marcelo Sternberg (L) and Prof. Ehud Gazit. The Chinese government recently decided to award its most prestigious academic award, the Changjiang Professorship, to two researchers from the George Wise School of Life Sciences at the Tel Aviv University: Prof. Marcelo Sternberg, Head of the Plant Ecology Laboratory from the School of Plant Sciences and Food Security; and Prof. Ehud Gazit, Head of the Belvatnik Center for Pharmaceutical Development, at the School of Molecular Cell Biology and...

IQ Consortium Publications Illustrate How Precompetitive Collaboration Drives Pharma Industry Innovation Share Article The IQ Consortium is excited to announce the publication of a special section in the Pharmaceutical Technology Regulatory Sourcebook eBook series! The eBook highlights five key case study areas developed by IQ Working Groups and Leadership Groups and builds on IQ’s earlier article, “Viewpoint: Precompetitive Collaboration Drives Pharma Industry Innovation” published to co...

Optimising spray-dried solid dispersions to improve solubility SHARES Manufacturing drug products with low solubility APIs (BCS type II and IV) has its challenges, in this article, Javier Gurrea, a Spray Drying Manufacturing Scientist at Idifarma, explains why spray drying offers a great way to overcome them. Today’s active pharmaceutical ingredients (API) are increasingly insoluble and that can pose serious problems for formulators looking to manage bioavailability and dosing of their formul...

Share: NEW YORK, NY, March 01, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) ("Tauriga" or the "Company"), a revenue generating, diversified life sciences company, with a proprietary line of CBD & CBG infused Supplement chewing gums (Flavors: Pomegranate, Blood Orange, Peach-Lemon, Pear Bellini, Mint, Black Currant), additional product offerings, as well as an ongoing Pharmaceutical Development initiative, today announced that it has acquired an equity s...

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Tauriga Sciences Inc. to Operate Virtual Exhibitor Booth at the CAMEX 2021 National Association ... Tauriga SciencesFebruary 16, 2021 GMT Tauriga Virtual Booth The Company is an Approved Affiliate Vendor of The NACS (Vendor ID # 113921)  NEW YORK, NY, Feb. 16, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire  -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generatin...

Tauriga Sciences Inc. to Commence Development of its 1st Full Spectrum CBD Infused Edibles Product Line February 12, 2021 10:45 ET | Source: Tauriga Sciences Tauriga Sciences NEW YORK, NY , Feb. 12, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating, diversified life sciences company, with a proprietary line of CBD & CBG infused Supplement chewing gums (Flavors: Pomegranate, B...

Press release content from Globe Newswire. The AP news staff was not involved in its creation. Tauriga Sciences, Inc. Establishes Two Additional UPC Category Classifications for its Flagship ... Tauriga SciencesFebruary 8, 2021 GMT These Additional Classifications are: Tauri-Gum™ Cases (8 Retail Boxes) & Tauri-Gum™ Shipment Crates (48 Retail Boxes) These Additional Classifications are: Tauri-Gum™ Cases (8 Retail Boxes) & Tauri-Gum™ Shipment Crates (48 Retail Boxes) These Additional Clas...